<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2007-11-3-29-47</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-875</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ И ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS AND LECTURES</subject></subj-group></article-categories><title-group><article-title>ОКСИДАТИВНЫЙ  СТРЕСС  И  ХРОНИЧЕСКАЯ  БОЛЕЗНЬ  ПОЧЕК</article-title><trans-title-group xml:lang="en"><trans-title>OXIDATIVE STRESS AND CHRONIC KIDNEY DISEASE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тугушева</surname><given-names>Ф. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Tugusheva</surname><given-names>F. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зубина</surname><given-names>И. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zubina</surname><given-names>I. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Митрофанова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Mitrofanova</surname><given-names>O. V.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Научно-исследовательский институт нефрологии Санкт-Петербургского государственного медицинского университета им. акад.  И.П.Павлова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>10</day><month>03</month><year>2007</year></pub-date><volume>11</volume><issue>3</issue><fpage>29</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Тугушева Ф.А., Зубина И.М., Митрофанова О.В., 2007</copyright-statement><copyright-year>2007</copyright-year><copyright-holder xml:lang="ru">Тугушева Ф.А., Зубина И.М., Митрофанова О.В.</copyright-holder><copyright-holder xml:lang="en">Tugusheva F.A., Zubina I.M., Mitrofanova O.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/875">https://journal.nephrolog.ru/jour/article/view/875</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>оксидативный стресс</kwd><kwd>хроническая болезнь почек</kwd></kwd-group><kwd-group xml:lang="en"><kwd>oxidative stress</kwd><kwd>chronic kidney disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Galle J, Wanner C. Oxidative stress and vascular injury – relevant for atherogenesis in uraemic patients? Nephrol Dial Transplant 1997; 12(12): 2480-2483</mixed-citation><mixed-citation xml:lang="en">Galle J, Wanner C. Oxidative stress and vascular injury – relevant for atherogenesis in uraemic patients? Nephrol Dial Transplant 1997; 12(12): 2480-2483</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Locatelli F, Canaud B, Eckardt K-U et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18(7): 1272-1280</mixed-citation><mixed-citation xml:lang="en">Locatelli F, Canaud B, Eckardt K-U et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003; 18(7): 1272-1280</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tepel M. Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uremia. Nephrol Dial Transplant 2003; 18(8): 1439-1442</mixed-citation><mixed-citation xml:lang="en">Tepel M. Oxidative stress: does it play a role in the genesis of essential hypertension and hypertension of uremia. Nephrol Dial Transplant 2003; 18(8): 1439-1442</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Петрович ЮА, Гуткин ДВ. Свободно-радикальное окисление и роль в патогенезе воспаления, ишемии и стресса. Патол физиол эксперим терапия 1986; (5): 85-92</mixed-citation><mixed-citation xml:lang="en">Петрович ЮА, Гуткин ДВ. Свободно-радикальное окисление и роль в патогенезе воспаления, ишемии и стресса. Патол физиол эксперим терапия 1986; (5): 85-92</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рудько ИА, Балашова ТС, Кубатиев АА, Еpмоленко ВМ. Состояние пpооксидантной и антиоксидантной систем эpитpоцитов у больных с хpонической почечной недостаточностью. Теp apх1995; 67(8): 7-9</mixed-citation><mixed-citation xml:lang="en">Рудько ИА, Балашова ТС, Кубатиев АА, Еpмоленко ВМ. Состояние пpооксидантной и антиоксидантной систем эpитpоцитов у больных с хpонической почечной недостаточностью. Теp apх1995; 67(8): 7-9</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Li J-V, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 221-226</mixed-citation><mixed-citation xml:lang="en">Li J-V, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 221-226</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ward RA, McLeish KR. Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrol Dial Transplant 2004; 19(7): 1702-1707</mixed-citation><mixed-citation xml:lang="en">Ward RA, McLeish KR. Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure? Nephrol Dial Transplant 2004; 19(7): 1702-1707</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Descamps-Latscha B, Khoa TN, Witko-Sarsat V et al. Oxidative stress and cardiovascular disease in end stage renal failure. In.: Loscalzo J. and G.M. London, eds. Cardiovascular disease in end-stage renal failure. University Press, Oxford 2000; 245-272</mixed-citation><mixed-citation xml:lang="en">Descamps-Latscha B, Khoa TN, Witko-Sarsat V et al. Oxidative stress and cardiovascular disease in end stage renal failure. In.: Loscalzo J. and G.M. London, eds. Cardiovascular disease in end-stage renal failure. University Press, Oxford 2000; 245-272</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Zalba G, Fortuсo A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant 2006; 21: 2686-2690</mixed-citation><mixed-citation xml:lang="en">Zalba G, Fortuсo A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant 2006; 21: 2686-2690</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">(Pryor WA) Пpайеp У. Свободные pадикалы в биологии (под pед. У.Пpайеpа), в 2-х томах. Миp, М., 1979; Том 1: 318 с.; Том 2: 328</mixed-citation><mixed-citation xml:lang="en">(Pryor WA) Пpайеp У. Свободные pадикалы в биологии (под pед. У.Пpайеpа), в 2-х томах. Миp, М., 1979; Том 1: 318 с.; Том 2: 328</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Narsipur SS, Peterson OW, Smith R et al. Mechanisms of glomerular immune injury: effects of antioxidant treatment. J Am Soc Nephrol 2003; 14: 1748-1755</mixed-citation><mixed-citation xml:lang="en">Narsipur SS, Peterson OW, Smith R et al. Mechanisms of glomerular immune injury: effects of antioxidant treatment. J Am Soc Nephrol 2003; 14: 1748-1755</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Gwinner W, Grone HJ. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant 2000; 15(8): 1127-1132</mixed-citation><mixed-citation xml:lang="en">Gwinner W, Grone HJ. Role of reactive oxygen species in glomerulonephritis. Nephrol Dial Transplant 2000; 15(8): 1127-1132</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Salacci P, Hayoz D. Oxidative stress as the triggering event for vascular remodeling. Nephrol Dial Transplant 1998; 13 (6): 1343-1346</mixed-citation><mixed-citation xml:lang="en">Salacci P, Hayoz D. Oxidative stress as the triggering event for vascular remodeling. Nephrol Dial Transplant 1998; 13 (6): 1343-1346</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Delles C, Klingbeil AU, Schneider MP et al. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 2004; 19(6): 1392-1397</mixed-citation><mixed-citation xml:lang="en">Delles C, Klingbeil AU, Schneider MP et al. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 2004; 19(6): 1392-1397</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003; 18(3): 463-466</mixed-citation><mixed-citation xml:lang="en">Vanholder R, Glorieux G, Lameire N. Uraemic toxins and cardiovascular disease. Nephrol Dial Transplant 2003; 18(3): 463-466</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Меншутина МА. Сравнительная оценка реактивности сосудов, как формы дисфункции эндотелия у больных атеросклерозом и хронической болезнью почек. Нефрология 2004; 8(3): 56-61</mixed-citation><mixed-citation xml:lang="en">Меншутина МА. Сравнительная оценка реактивности сосудов, как формы дисфункции эндотелия у больных атеросклерозом и хронической болезнью почек. Нефрология 2004; 8(3): 56-61</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Morimoto H, Nakao K, Fukuoka K et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2775-2782</mixed-citation><mixed-citation xml:lang="en">Morimoto H, Nakao K, Fukuoka K et al. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 2005; 20: 2775-2782</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Pfeilschifter J, Eberhardt W, Huwiler A. Nitric oxide and mechanisms of redox signaling, J Am Soc Nephrol 2003; 14 [Suppl. 3]: 237-240</mixed-citation><mixed-citation xml:lang="en">Pfeilschifter J, Eberhardt W, Huwiler A. Nitric oxide and mechanisms of redox signaling, J Am Soc Nephrol 2003; 14 [Suppl. 3]: 237-240</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Wolin MS, Ahmad M, Gupte SA. The sources of oxidative stress in the vessel wall. Kidney Int 2005; 67: 1659-1661</mixed-citation><mixed-citation xml:lang="en">Wolin MS, Ahmad M, Gupte SA. The sources of oxidative stress in the vessel wall. Kidney Int 2005; 67: 1659-1661</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kielstein JT, Bode-Boger SM, Haller H, Fliser D. Functional changes in the aging kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003;18: 1245-1248</mixed-citation><mixed-citation xml:lang="en">Kielstein JT, Bode-Boger SM, Haller H, Fliser D. Functional changes in the aging kidney: is there a role for asymmetric dimethylarginine? Nephrol Dial Transplant 2003;18: 1245-1248</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Владимиров ЮА, Арчаков АИ. Перекисное окисление липидов в биологических мембранах. Наука, М., 1972; 252</mixed-citation><mixed-citation xml:lang="en">Владимиров ЮА, Арчаков АИ. Перекисное окисление липидов в биологических мембранах. Наука, М., 1972; 252</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Witko-Sarsat V, Khoa TN, Jungers P et al. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999; 14 [Suppl. 1]: 76-78</mixed-citation><mixed-citation xml:lang="en">Witko-Sarsat V, Khoa TN, Jungers P et al. Advanced oxidation protein products as a novel molecular basis of oxidative stress in uraemia. Nephrol Dial Transplant 1999; 14 [Suppl. 1]: 76-78</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Мееpсон ФЗ. Антиоксидантные фактоpы оpганизма как система естественной пpофилактики стpессоpных повpеждений. Физиология адаптационных пpоцессов. Hаука, М., 1986; 607-619</mixed-citation><mixed-citation xml:lang="en">Мееpсон ФЗ. Антиоксидантные фактоpы оpганизма как система естественной пpофилактики стpессоpных повpеждений. Физиология адаптационных пpоцессов. Hаука, М., 1986; 607-619</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Taki K, Takayama F, Tsuruta Y, Niwa T. Oxidative stress, advanced glycation end products and coronary artery calcification in haemodialysis patients. Kidney Int 2006; 70: 218-224</mixed-citation><mixed-citation xml:lang="en">Taki K, Takayama F, Tsuruta Y, Niwa T. Oxidative stress, advanced glycation end products and coronary artery calcification in haemodialysis patients. Kidney Int 2006; 70: 218-224</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Губский ЮИ, Беленичев ИФ, Левицкий ЕЛ, Павлов СВ, Горюшко АГ. Механизмы развития когнитивного дефицита под действием кислородных радикалов в условиях стресса. Сучасні проблеми токсикологii 2006; (3):</mixed-citation><mixed-citation xml:lang="en">Губский ЮИ, Беленичев ИФ, Левицкий ЕЛ, Павлов СВ, Горюшко АГ. Механизмы развития когнитивного дефицита под действием кислородных радикалов в условиях стресса. Сучасні проблеми токсикологii 2006; (3):</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 254-258</mixed-citation><mixed-citation xml:lang="en">Forbes JM, Cooper ME, Oldfield MD, Thomas MC. Role of advanced glycation end products in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 254-258</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sakurai S, Yonekira H, Yamamoto Y et al. The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 259-263</mixed-citation><mixed-citation xml:lang="en">Sakurai S, Yonekira H, Yamamoto Y et al. The AGE-RAGE system and diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 259-263</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Amore A, Cirina P, Conti G et al. Amadori-confogurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol Dial Transplant2004; 19: 53-60</mixed-citation><mixed-citation xml:lang="en">Amore A, Cirina P, Conti G et al. Amadori-confogurated albumin induces nitric oxide-dependent apoptosis of endothelial cells: a possible mechanism of diabetic vasculopathy. Nephrol Dial Transplant2004; 19: 53-60</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Iacobini C, Amadio L, Oddi G et al. Role of galectin-3 in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 264-270</mixed-citation><mixed-citation xml:lang="en">Iacobini C, Amadio L, Oddi G et al. Role of galectin-3 in diabetic nephropathy. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 264-270</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997; 12(2): 255-258</mixed-citation><mixed-citation xml:lang="en">Miyata T, Maeda K, Kurokawa K, van Ypersele de Strihou C. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. Nephrol Dial Transplant 1997; 12(2): 255-258</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">(Murray RK, Granner DK, Mayes PA, Rodwell VW). Маppи Р, Гpеннеp Д, Мейес П, Родуэлл В. Биохимия человека. В 2-х томах. Миp, М., 1993; Том 1: 384 с.; Том 2: 416 с.</mixed-citation><mixed-citation xml:lang="en">(Murray RK, Granner DK, Mayes PA, Rodwell VW). Маppи Р, Гpеннеp Д, Мейес П, Родуэлл В. Биохимия человека. В 2-х томах. Миp, М., 1993; Том 1: 384 с.; Том 2: 416 с.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Денисов ЛH, Лобаpева ЛС, Якушева ЕО. Антиоксидантные эффекты витаминов. Значение в pевматологии. Теp apх 1994; 66(5): 82-86</mixed-citation><mixed-citation xml:lang="en">Денисов ЛH, Лобаpева ЛС, Якушева ЕО. Антиоксидантные эффекты витаминов. Значение в pевматологии. Теp apх 1994; 66(5): 82-86</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Спиpичев ВБ, Коль ИЛ. Жиpоpаствоpимые витамины и мембpаны. Жуpнал Всесоюзного химического общества им. Д.И.Менделеева 1978; 23(4):425-434</mixed-citation><mixed-citation xml:lang="en">Спиpичев ВБ, Коль ИЛ. Жиpоpаствоpимые витамины и мембpаны. Жуpнал Всесоюзного химического общества им. Д.И.Менделеева 1978; 23(4):425-434</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Saran R, Novak JE, Desai A et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant 2003; 18(11): 2415-2420</mixed-citation><mixed-citation xml:lang="en">Saran R, Novak JE, Desai A et al. Impact of vitamin E on plasma asymmetric dimethylarginine (ADMA) in chronic kidney disease (CKD): a pilot study. Nephrol Dial Transplant 2003; 18(11): 2415-2420</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Климов АH, Кожемякин ЛА, Плесков ВМ, Андpеева ЛМ. Антиоксидантный эффект липопpотеидов высокой плотности пpи пеpекисном окислени липопpотеидов низкой плотности. Бюл экспеpим биол мед 1987; (5): 550-552</mixed-citation><mixed-citation xml:lang="en">Климов АH, Кожемякин ЛА, Плесков ВМ, Андpеева ЛМ. Антиоксидантный эффект липопpотеидов высокой плотности пpи пеpекисном окислени липопpотеидов низкой плотности. Бюл экспеpим биол мед 1987; (5): 550-552</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membrane? Arch Biochem Biophys 1983; 221(1): 281-290</mixed-citation><mixed-citation xml:lang="en">Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membrane? Arch Biochem Biophys 1983; 221(1): 281-290</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Maggio B, Doplok AT, Lucy JA. Interactions of tocopherols and ubiquinones with monolayers of phospholipids Biochem J 1977; 161(1): 111-121</mixed-citation><mixed-citation xml:lang="en">Maggio B, Doplok AT, Lucy JA. Interactions of tocopherols and ubiquinones with monolayers of phospholipids Biochem J 1977; 161(1): 111-121</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Eaton P, Jones ME, McGregor E et al. Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 290-296</mixed-citation><mixed-citation xml:lang="en">Eaton P, Jones ME, McGregor E et al. Reversible cysteine-targeted oxidation of proteins during renal oxidative stress. J Am Soc Nephrol 2003; 14 [Suppl. 3]: 290-296</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Говоpова HЮ, Шаpонов БП, Лызлова СH. Окислительное повpеждение эpитpоцитов миелопеpоксидазой. Защитное действие сывоpоточных белков. Бюл экспеpим биологии и медицины 1989; (4): 428-430</mixed-citation><mixed-citation xml:lang="en">Говоpова HЮ, Шаpонов БП, Лызлова СH. Окислительное повpеждение эpитpоцитов миелопеpоксидазой. Защитное действие сывоpоточных белков. Бюл экспеpим биологии и медицины 1989; (4): 428-430</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Шаpонов БП, Говоpова HЮ, Лызлова СH. Антиокислительные свойства и дегpадация белков сывоpотки активными фоpмами кислоpода (О 2 ,ОСl), генеpиpуемыми стимулиpованными нейтpофилами. Биохимия 1988; 53(5): 816-825</mixed-citation><mixed-citation xml:lang="en">Шаpонов БП, Говоpова HЮ, Лызлова СH. Антиокислительные свойства и дегpадация белков сывоpотки активными фоpмами кислоpода (О 2 ,ОСl), генеpиpуемыми стимулиpованными нейтpофилами. Биохимия 1988; 53(5): 816-825</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Vuong TD, Braam B, Willekes-Koolschijn N et al. Hypoalbuminemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003; 18(8): 1485-1492</mixed-citation><mixed-citation xml:lang="en">Vuong TD, Braam B, Willekes-Koolschijn N et al. Hypoalbuminemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant 2003; 18(8): 1485-1492</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Миллеp ЮИ. Связывание ксенобиотиков альбумином сывоpотки кpови. Клинич лаб диагностика 1993; (1): 34-40</mixed-citation><mixed-citation xml:lang="en">Миллеp ЮИ. Связывание ксенобиотиков альбумином сывоpотки кpови. Клинич лаб диагностика 1993; (1): 34-40</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Ok E, Basnakian AG, Apostolov EO et al. Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease. Kidney Int 2005; 68: 173-178</mixed-citation><mixed-citation xml:lang="en">Ok E, Basnakian AG, Apostolov EO et al. Carbamylated low-density lipoprotein induces death of endothelial cells: A link to atherosclerosis in patients with kidney disease. Kidney Int 2005; 68: 173-178</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Митpофанова ОВ, Куликова АИ. Состояние фосфолипидов кpови пpи ХГH. В: Нефpология (Рабочее совещание нефpологов Севеpо-Запада России): Сбоpник матеpиалов. Санкт-Петеpбуpг, 1996: 72-76</mixed-citation><mixed-citation xml:lang="en">Митpофанова ОВ, Куликова АИ. Состояние фосфолипидов кpови пpи ХГH. В: Нефpология (Рабочее совещание нефpологов Севеpо-Запада России): Сбоpник матеpиалов. Санкт-Петеpбуpг, 1996: 72-76</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Zocalli C. Traditional and emerging cardiovascular and renal risk factors: an epidemiological perspective. Kidney Int 2006; 70: 26-33</mixed-citation><mixed-citation xml:lang="en">Zocalli C. Traditional and emerging cardiovascular and renal risk factors: an epidemiological perspective. Kidney Int 2006; 70: 26-33</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Смиpнов АВ. Дислипопpотеидемия как один из неиммунных механизмов пpогpессиpования склеpотических пpоцессов в почечной паpенхиме. Hефpология 1997; (2): 7-12</mixed-citation><mixed-citation xml:lang="en">Смиpнов АВ. Дислипопpотеидемия как один из неиммунных механизмов пpогpессиpования склеpотических пpоцессов в почечной паpенхиме. Hефpология 1997; (2): 7-12</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Chana RS, Wheeler DC, Thomas GJ et al. Low-density lipoprotein stimulates mesangial cells proteoglycan and hyaluronan synthesis Nephrol Dial Transplant 2000; 15(2): 167-172</mixed-citation><mixed-citation xml:lang="en">Chana RS, Wheeler DC, Thomas GJ et al. Low-density lipoprotein stimulates mesangial cells proteoglycan and hyaluronan synthesis Nephrol Dial Transplant 2000; 15(2): 167-172</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Багиpова РД, Алекпеpова HВ, Синяченко ОВ и дp. Исследование пpодуктов пеpекисного окисления и pенальных функций пpи нефpогенной гипеpтензии. Вpач дело 1993; (2-3): 81-85</mixed-citation><mixed-citation xml:lang="en">Багиpова РД, Алекпеpова HВ, Синяченко ОВ и дp. Исследование пpодуктов пеpекисного окисления и pенальных функций пpи нефpогенной гипеpтензии. Вpач дело 1993; (2-3): 81-85</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Pallone TL. Is oxidative stress differentially regulated in the renal cortex and medulla? Nature Clinical Practice Nephrology 2006; 2(3): 118-119</mixed-citation><mixed-citation xml:lang="en">Pallone TL. Is oxidative stress differentially regulated in the renal cortex and medulla? Nature Clinical Practice Nephrology 2006; 2(3): 118-119</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Bevers M, van Faassen EE, Vuong TD et al. Low albumin levels increase endothelial NO production and increase vascular NO sensitivity. Nephrol Dial Transplant 2006;21: 3443-3449</mixed-citation><mixed-citation xml:lang="en">Bevers M, van Faassen EE, Vuong TD et al. Low albumin levels increase endothelial NO production and increase vascular NO sensitivity. Nephrol Dial Transplant 2006;21: 3443-3449</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Bayers B, Pastor MC, Bonal J et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis – role of seniority and intravenous ferrotherapy: analysis at 4 year follow-up. Nephrol Dial Transplant 2006; 21: 984-990</mixed-citation><mixed-citation xml:lang="en">Bayers B, Pastor MC, Bonal J et al. Oxidative stress, inflammation and cardiovascular mortality in haemodialysis – role of seniority and intravenous ferrotherapy: analysis at 4 year follow-up. Nephrol Dial Transplant 2006; 21: 984-990</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Fumeron C, Nguyen-Khoa T, Saltiel C et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005;20: 1874-1879</mixed-citation><mixed-citation xml:lang="en">Fumeron C, Nguyen-Khoa T, Saltiel C et al. Effects of oral vitamin C supplementation on oxidative stress and inflammation status in haemodialysis patients. Nephrol Dial Transplant 2005;20: 1874-1879</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int 2005; 68: 2180-2188</mixed-citation><mixed-citation xml:lang="en">Stewart T, Jung FF, Manning J, Vehaskari VM. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int 2005; 68: 2180-2188</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Galle J, Seibold S. Has the time come to use antioxidant therapy in uraemic patients? Nephrol Dial Transplant 2003; 18(8): 1452-1455</mixed-citation><mixed-citation xml:lang="en">Galle J, Seibold S. Has the time come to use antioxidant therapy in uraemic patients? Nephrol Dial Transplant 2003; 18(8): 1452-1455</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Shimizu MHM, Coimbra TM, de Araujo M et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; 68: 2208-2217</mixed-citation><mixed-citation xml:lang="en">Shimizu MHM, Coimbra TM, de Araujo M et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; 68: 2208-2217</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
